BioCentury

Current Editions

Financial innovation needed to advance gene therapy

Report from ICER and NEWDIGS suggests strategies, reforms to help payers adjust to one-time therapies

Market Access

Product Development

Clinical report: Sanofi data advances pair of autoimmune disease mechanisms

Plus: Neurocrine hits in Phase II depression study and updates from Cerevel, Sage, Ventus, Lilly and AbbVie

Deals

Incyte’s hopes for mast cell program spur $750M Escient takeout

Deal gives Incyte clinical molecules for inflammatory, dermatological disorders

Management Tracks

Evotec names Christian Wojczewski CEO

Plus: Novartis proposes Giovanni Caforio as chair and updates from Congruence, Recludix, Calluna and more

BioCentury ISSN 1097-7201